home / stock / crdl:cc / crdl:cc short
Short Information | Cardiol Therapeutics Inc. (TSXC:CRDL:CC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 0 |
Total Actual Volume | 0 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 0 |
Average Short Percentage | 0.00% |
Is there a CRDL:CC Short Squeeze or Breakout about to happen?
See the CRDL:CC Short Analysis for free Sign up or Login
Powered by Squeeze Report
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Inc. Company Name:
CRDL:CC Stock Symbol:
TSXC Market:
Scope of presentation included trial design, rationale, and blinded baseline data on first 50 patients randomized into the Phase II study evaluating CardiolRx™ in patients with acute myocarditis ARCHER trial rationale and design also accepted for publication in the journal ESC Heart Fai...
Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in patients with recurrent pericarditis, with topline results expected in Q2 2024 CardiolRx™ granted U.S. FDA Orphan Drug Designation for the treatment of pericarditis, which includes recurrent p...
Topline Results Expected in Q2 2024 This is a Designated News Release. Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical ...